New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 3, 2017 – Mylan launched an AP-rated generic version of Teva’s Copaxone (glatiramer) 40 mg/mL injection.
Download PDF
Return to publications
